n
a
v
Portfolio
Genetics
AmplideX® mPCR FMR1 Kit
AmplideX® PCR/CE FMR1 Kit
AmplideX® FMR1 Controls
Xpansion Interpreter®
AmplideX® PCR/CE
SMN1/2
Plus Kit
AmplideX® PCR/CE
CFTR
Kit
AmplideX® PCR/CE C9orf72 Kit
AmplideX® PCR/CE
DMPK
Kit
AmplideX® PCR/CE
HTT
Kit
AmplideX® TRIO
Oncology
QuantideX® qPCR BCR-ABL IS Kit
QuantideX® qPCR BCR-ABL minor Kit
MolecularDx Controls
Catalog of Armored Products
SARS CoV-2 Controls
Made-To-Order Armored and Nucleic Acid
Molecular Assay Reagents
Custom & Companion Diagnostics
Partnered R&D
CAP-Accredited CLIA Lab
CTA Testing Site
Validated Platforms & Assays
Companion Diagnostics
Enabling Technologies
Assay Chemistries
Bioinformatics
Product Development Process
Resources
Publications
Articles
Whitepapers
Posters
Disease Information
Fragile X Syndrome
Dementia
Chronic Myeloid Leukemia (CML)
Other Resources
Videos
Carrier Screening Guide
Safety Data Sheets
Sales Contacts
Our Culture
Employee Spotlights
Culture & Heritage
Sales Contacts
Contact
About
Leadership Team
Culture and Heritage
News
Upcoming Events
Business Development
Careers
Search
News
Home
News
Press Releases
Year
Select Year
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
March 14, 2017
Asuragen Launches the AmplideX® PCR/CE TOMM40 Kit1 Expanding Portfolio into the Alzheimer’s and Cognitive Impairment Space
Share
February 20, 2017
Asuragen and Thermo Fisher Scientific to Collaborate on Diagnostic Kits for 3500 Dx Series Genetic Analyzer
Share
November 8, 2016
Asuragen to Present at 2016 Association for Molecular Pathology Annual Meeting
Share
November 1, 2016
Asuragen Launches QuantideX® NGS RNA Lung Cancer Kit (RUO)
Share
August 9, 2016
Asuragen Develops Armored RNA Quant® Zika Virus Control
Share
July 25, 2016
Asuragen’s QuantideX® qPCR BCR-ABL IS Kit Receives FDA Premarket Clearance for Monitoring Minimal Residual Disease in Chronic Myeloid Leukemia
Share
July 6, 2016
Asuragen Launches the AmplideX® PCR/CE C9orf72 Kit for High-Resolution Genotyping of GC-rich Repeat Expansions Relevant to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Share
April 18, 2016
Asuragen to Present Expansion of Next-Generation Sequencing Portfolio at American Association of Cancer Research Annual Meeting
Share
February 10, 2016
Asuragen Names Colin Hill Senior Vice President of Commercial Operations
Share
December 5, 2015
Asuragen Launches AmplideX® PCR/CE FMR1 Reporter*, a Fully Automated Software Solution for Accurate Sizing of the FMR1 CGG Repeat Region
Share
Prev
1
2
3
4
5
6
7
8
Next
About
About
Leadership Team
Culture and Heritage
News
Upcoming Events
Business Development
Back To
Top